---
title: "NRx Pharmaceuticals pushes Kadima dispute into arbitration amid acquisition lawsuit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290873818.md"
description: "NRx Pharmaceuticals has initiated arbitration against Kadima Neuropsychiatry Institute regarding a failed acquisition of HOPE Therapeutics. The dispute involves alleged unmet closing conditions, including asset title and material adverse changes. While Kadima sued for specific performance to join the HOPE clinic network, NRx expects San Diego courts to remand the case to arbitration, deeming it non-material to shareholders."
datetime: "2026-06-25T20:01:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290873818.md)
  - [en](https://longbridge.com/en/news/290873818.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290873818.md)
generator: "portal-rs"
---

# NRx Pharmaceuticals pushes Kadima dispute into arbitration amid acquisition lawsuit

-   NRX Pharmaceuticals disclosed it has compelled arbitration with Kadima Neuropsychiatry Institute over a failed HOPE Therapeutics acquisition. \* The dispute centers on alleged unmet closing conditions, including clear title to assets, cited material adverse change, and other issues. \* Kadima and its founder, William Feifel, sued to force the deal through specific performance, seeking to join the HOPE clinic network. \* NRX said it expects San Diego courts to send the case back to arbitration, calling the matter non-material to shareholders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606251601PRIMZONEFULLFEED9752877) on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [NRXP.US](https://longbridge.com/en/quote/NRXP.US.md)
- [NRXPW.US](https://longbridge.com/en/quote/NRXPW.US.md)

## Related News & Research

- [08:32 ETMindtrip Partners With The San Diego Tourism Authority To Reimagine How Travelers Discover San Diego](https://longbridge.com/en/news/297325959.md)
- [Generational Group Advises Cantor BioConnect in its Sale to Prairie Capital](https://longbridge.com/en/news/297685099.md)
- [Haig Partners Serves as Exclusive Advisor on the Sale of O’Gara Coach San Diego Dealerships](https://longbridge.com/en/news/297068383.md)
- [05:56 ETJake's Motorcars Offers Online Pre-Approval for Financing Your Next Luxury Buy in San Diego, CA](https://longbridge.com/en/news/297496139.md)
- [OpenAI urges enterprises to scale agent-driven workflows as AI shifts from assistance to execution](https://longbridge.com/en/news/297682427.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**